208 related articles for article (PubMed ID: 37225838)
1. Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells.
Lv X; Zhu S; Wu J; Shi J; Wei Q; Li T; Yang N; Liu C; Qi L; Zang G; Cheng H; Yang Z; Jin C; Wang Y; Cui J; Ueno H; Liu YJ; Chen J
Cell Mol Immunol; 2023 Jul; 20(7):808-819. PubMed ID: 37225838
[TBL] [Abstract][Full Text] [Related]
2. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells.
Komlósi ZI; Kovács N; van de Veen W; Kirsch AI; Fahrner HB; Wawrzyniak M; Rebane A; Stanic B; Palomares O; Rückert B; Menz G; Akdis M; Losonczy G; Akdis CA
J Allergy Clin Immunol; 2018 Jul; 142(1):178-194.e11. PubMed ID: 28939410
[TBL] [Abstract][Full Text] [Related]
3. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.
Paclik D; Stehle C; Lahmann A; Hutloff A; Romagnani C
Eur J Immunol; 2015 Oct; 45(10):2766-72. PubMed ID: 26249010
[TBL] [Abstract][Full Text] [Related]
4. ICOS Costimulation Differentially Affects T Cells in Secondary Lymphoid Organs and Inflamed Tissues.
Van DV; Bauer L; Kroczek RA; Hutloff A
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):437-447. PubMed ID: 29676593
[TBL] [Abstract][Full Text] [Related]
5. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
6. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
[TBL] [Abstract][Full Text] [Related]
7. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
Paulos CM; Carpenito C; Plesa G; Suhoski MM; Varela-Rohena A; Golovina TN; Carroll RG; Riley JL; June CH
Sci Transl Med; 2010 Oct; 2(55):55ra78. PubMed ID: 20980695
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.
Zhang J; Guo Q; Dai D; Yu J; Wang L; Wu Z; Ding H; Shen N; Duan Y
Biomaterials; 2022 Oct; 289():121766. PubMed ID: 36087549
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid tissue inducer-A divergent member of the ILC family.
Zhong C; Zheng M; Zhu J
Cytokine Growth Factor Rev; 2018 Aug; 42():5-12. PubMed ID: 29454785
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
11. ICOS+ Th cells produce distinct cytokines in different mucosal immune responses.
Bonhagen K; Liesenfeld O; Stadecker MJ; Hutloff A; Erb K; Coyle AJ; Lipp M; Kroczek RA; Kamradt T
Eur J Immunol; 2003 Feb; 33(2):392-401. PubMed ID: 12645936
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of IL-17A
Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
Liu Z; Liu S; Zhang Y; Zeng W; Wang S; Ji P; Pan M; Zhu C; Wang Y
Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
[TBL] [Abstract][Full Text] [Related]
14. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
Maazi H; Patel N; Sankaranarayanan I; Suzuki Y; Rigas D; Soroosh P; Freeman GJ; Sharpe AH; Akbari O
Immunity; 2015 Mar; 42(3):538-51. PubMed ID: 25769613
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Satoh-Takayama N
Int Immunol; 2016 Jan; 28(1):29-34. PubMed ID: 26462712
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the mystery of ILC3s: Their functions and interactions in mucosal immunity.
Liang B; Xing D
Int Immunopharmacol; 2023 Oct; 123():110772. PubMed ID: 37552906
[TBL] [Abstract][Full Text] [Related]
18. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
Pontarini E; Murray-Brown WJ; Croia C; Lucchesi D; Conway J; Rivellese F; Fossati-Jimack L; Astorri E; Prediletto E; Corsiero E; Romana Delvecchio F; Coleby R; Gelbhardt E; Bono A; Baldini C; Puxeddu I; Ruscitti P; Giacomelli R; Barone F; Fisher B; Bowman SJ; Colafrancesco S; Priori R; Sutcliffe N; Challacombe S; Carlesso G; Tappuni A; Pitzalis C; Bombardieri M
Ann Rheum Dis; 2020 Dec; 79(12):1588-1599. PubMed ID: 32963045
[TBL] [Abstract][Full Text] [Related]
19. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
20. ICOS promotes group 2 innate lymphoid cell activation in lungs.
Kamachi F; Isshiki T; Harada N; Akiba H; Miyake S
Biochem Biophys Res Commun; 2015 Aug; 463(4):739-45. PubMed ID: 26049110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
